Pembrolizumab plus either epacadostat or placebo for cisplatin-ineligible urothelial carcinoma: results from the ECHO-307/KEYNOTE-672 study
暂无分享,去创建一个
A. Balar | P. Grivas | M. S. van der Heijden | A. Peer | D. Trukhin | R. Kataria | R. Leibowitz | Calvin Jia | Ronald de Wit | Andrea Necchi | H. Gurney | Boris Alekseev | Francis X. Parnis | M. De Santis | Jason Clark | Mihaela Munteanu